Skip to content

The role of Alexithymia in diabetes treatment

The assessment of alexithymia effect on type II diabetic patients’ self-care through and HbA1c acceptance and commitment therapy (ACT)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201211275440N2
Enrollment
100
Registered
2013-05-13
Start date
2012-09-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II diabetes. Non-insulin-dependent diabetes mellitus

Interventions

One-day educational workshop
Behavior
Lifestyle
It is a group therapy intervention. ACT treatment will be implemented in 8 session and three phases, as follows: The first phase (sessions 3-1) education and information, in this phase,patients, after

Sponsors

Institute of Endocrinology and Metabolism of Beheshti University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- age range is between 40 to 70 years old 2- Minimum educational degree is Diploma 3- disease duration is between one and five years 4 - It is necessary that the subjects during the study don't use psychotherapy programs and Drug changes outside of the educational and therapeutic intervention of study Exclusion criteria: 1 - Being affected by other types of diabetes 2- Being affected by severe diabetic complications that may impede the investigation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Self Care. Timepoint: Before treatment, after treatment and 3 months after treatment. Method of measurement: Summary of Diabetes Self-Care Activities.;Alexithymia. Timepoint: Before treatment, after treatment and 3 months after treatment. Method of measurement: Toronto Alexithymia Scale.

Secondary

MeasureTime frame
HbA1c. Timepoint: Befor treatment, after treatment and 3 months after treatment. Method of measurement: Blood tests Mg/dl.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Parisa Amiri

Institute of Endocrinology and Metabolism of Beheshti University

parisaamiri@yahoo.com+98 21 2243 2500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026